Retatrutide

Retatrutide is an investigational triple receptor agonist that targets the GIP, GLP-1, and glucagon receptors at once. They are the three incretin and metabolic pathways most studied in energy-balance and glycemic research. It is the newest compound in the GLP-1 family and the most-requested peptide in the metabolic class. Supplied as a lyophilized research-grade powder for reconstitution. For laboratory research use only. Not for human consumption.